Potential Clinical Value of 5-Hydroxytryptamine Receptor 3C as a Prognostic Biomarker for Lung Cancer

Figure 1

HTR3C, HTR3D, and HTR3E showed the highest amplification levels in NSCLC. (a) OncoPrint showing HTR3C, HTR3D, and HTR3E amplification in 18% of NSCLC cases. Colors indicate the type of genetic mutation (missense, in-frame, truncated, amplification, deletion, and fusion), and different cohorts are listed below the OncoPrint. Cancer type summary of HTR3A (b), HTR3B (c), HTR3C (d), HTR3D (e), and HTR3E (f) according to the lung cancer cohorts (cBioPortal). CAN = copy number alterations.

(a)

(b)

(c)

(d)

(e)

(f)